Latest Aptar News & Updates

See the latest news and media coverage for Aptar. We track all announcements, press releases, and industry mentions in real time, all in one place.

Aptar

Drug and consumer product dosing, dispensing and protection technologies

aptar.com

Headquarters: United States
Company type: Public company
Number of employees: 10,000+
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Aptar

In short: Aptar appointed Gael Touya as CEO, achieved record quarterly sales exceeding $1 billion, and expanded global pharmaceutical production.

Company announcements

September 11 Aptar

Aptar expands preservative-free production in Latin America

The company commissioned its APF line in Berazategui, Argentina, to improve local access and reduce lead times for drug delivery solutions.

September 9 Aptar

Gael Touya presents priorities to deliver long term value at Wells Fargo Healthcare Conference

The CEO highlighted Aptar's strategy to build on a strong foundation and create lasting stakeholder value.

September 1 Aptar

Aptar appoints Gael Touya as its new President and CEO

He assumes board membership alongside executive duties to drive innovation across packaging technologies. The transition aligns with corporate goals to enhance consumer and patient outcomes.

July 30 Aptar

Aptar reports second quarter 2026 results

Sales increased 6% to over $1 billion, net income $88 million, adjusted EPS $1.42.

Media coverage

Yesterday Meduza

Putin transferred assets of another foreign company, a manufacturer..., to temporary management

Vladimir Putin signed a decree transferring 100% of the shares in the French company Aptar Europe Holding to temporary management. 'Aptar Vladimir' owns a Russian plant for producing plastic...

September 1 AFP

Gaël Touya takes up his functions as chief executive officer of Aptar

AptarGroup, Inc., a global leader in drug administration, dosing and protection technologies, as well as in the distribution of consumer goods products, has...

July 31 The Globe and Mail

AptarGroup Earnings Call: Record Sales, Margin Squeeze

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities...

July 31 Seeking Alpha

Aptar projects Q3 adjusted EPS of $1.45-$1.53 as CEO transition set for September 1

Q2 2026 earnings call recap: record ~$1B sales, EPS beat, pharma/GLP-1 demand, Beauty fixes, and Q3 EPS guide $1.45-$1.53—read now.

Never miss news about Aptar

Track Aptar and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Aptar competitors & trending companies

Browse news for competitors to Aptar and other trending companies.